Tyto Acquisition Corp Prevail Therapeutics Inc. (PRVL) insider trading activity

PRVL Quotes by TradingView

Tyto Acquisition Corp is > 10% Shareholder of Prevail Therapeutics Inc.. Currently has a direct ownership of 100 shares of PRVL, which is worth approximately $2,297. The most recent transaction as insider was on Jan 22, 2021, when has been sold 34,284,789 shares (Common Stock) at a price of $22.5 per share, resulting in proceeds of $771,407,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100
0% 3M change
0% 12M change
Total Value Held $2,297

Tyto Acquisition Corp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 22 2021
BUY
Open market or private purchase
$771,407,752 $22.5 p/Share
34,284,789 Added 100.0%
100 Common Stock
TAC

Tyto Acquisition Corp

> 10% Shareholder
Indianapolis, IN

Track Institutional and Insider Activities on PRVL

Follow Prevail Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRVL shares.

Notify only if

Insider Trading

Get notified when an Prevail Therapeutics Inc. insider buys or sells PRVL shares.

Notify only if

News

Receive news related to Prevail Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRVL